Montelukast Prescribing at GREYSWOOD PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
543
Total Quantity
15.0K
NHS Cost
£769
vs National Avg
-20.7%
GREYSWOOD PRACTICE prescribed 543 items of Montelukast over the last 12 months at a cost of £769 to the NHS. This is 20.7% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jul 2026
54
Jul 2026
51
Jul 2026
45
Jul 2026
51
Jul 2026
36
Jul 2026
47
Jul 2026
69
Jul 2026
29
Jul 2026
38
Jul 2026
30
Jul 2026
38
Jul 2026
55
Prescribing Details
| Total Items | 543 |
|---|---|
| Total Quantity | 15,033 |
| Total NHS Cost | £769 |
| Presentations | 4 different forms |
| vs National Average | -20.7% |
Montelukast Prescribing Comparison
| This practice | 543 items |
|---|---|
| National average per practice | 685 items |
| Difference | -20.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.